Benjamin Cravatt III

Benjamin F. Cravatt III
Born (1970-04-13) April 13, 1970 (age 54)
EducationStanford University B.S. and B.A. (1992)
The Scripps Research Institute Ph.D. (1996)
Known forProteomics
Scientific career
FieldsChemical Biology
InstitutionsThe Scripps Research Institute
Vividion Therapeutics
ActivX Biosciences
Abide Therapeutics
Doctoral advisors

Benjamin Franklin Cravatt III is a professor in the Department of Chemistry at The Scripps Research Institute in La Jolla, California.[1] Considered a co-inventor of activity-based proteomics and a substantial contributor to research on the endocannabinoid system, he is a prominent figure in the nascent field of chemical biology. Cravatt was elected to the National Academy of Sciences in 2014,[1] and the American Academy of Arts and Sciences in 2016.[2] He is Gilula Chair of Chemical Biology, a Cope Scholar, and a Searle Scholar.

  1. ^ a b Viegas, Jennifer (2 February 2016). "Profile of Benjamin Cravatt". Proceedings of the National Academy of Sciences of the United States of America. 113 (5): 1109–11. Bibcode:2016PNAS..113.1109V. doi:10.1073/pnas.1525099113. PMC 4747733. PMID 26811454.
  2. ^ "National Academy of Sciences Members and Foreign Associates Elected" (Press release). United States: National Academy of Sciences. 29 April 2014. Archived from the original on 18 August 2015. Retrieved 2016-12-31. Cravatt, Benjamin F.; professor and chair, department of chemical physiology, The Scripps Research Institute, La Jolla, Calif.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne